News

Article August 21, 2025

The Brain’s Hidden Clean-Up Crew: NOMIS-Gladstone Fellow Myung Jin Yang’s Quest to Unlock the Mystery

NOMIS–Gladstone Fellow Myung Jin Yang is uncovering how the brain clears waste without traditional lymphatic vessels, a mystery that could shed light on aging and neurodegenerative diseases.

Graduate Students and Postdocs Profile Neurological Disease NOMIS

Article August 21, 2025

Fueling Discovery at the Frontiers of Neuroscience: The NOMIS-Gladstone Fellowship Program

The NOMIS-Gladstone Fellowship Program empowers early-career scientists to push the boundaries of neuroscience and unlock the brain’s deepest mysteries.

Institutional News Neurological Disease Mucke Lab NOMIS

Gladstone in the News August 14, 2025

With Vaccine Research Under Attack, It’s Time for California to Lead Again

The San Francisco Standard—In this opinion piece, Melanie Ott, director of the Gladstone Institute of Virology, writes that halting mRNA research right now is like banning ChatGPT—it's not just scientific negligence, but strategic self-sabotage. She proposes ways for California to take the lead by funding crucial research at the state level.

Gladstone Experts Cancer COVID-19 HIV/AIDS Infectious Disease Ott Lab

Gladstone in the News August 12, 2025

Deepak Srivastava Speaks About the Impact of Proposed NIH Budget Cuts

ABC7 News—Scientific advances have brought us closer than ever to contemplating cures for many devastating diseases—Parkinson’s, type 1 diabetes, certain cancers, HIV/AIDS. Gladstone President Deepak Srivastava comments on how proposed cuts to the National Institutes of Health budget would slow this progress and the very research that could save millions of lives. He explains why this moment matters and why continued investment in science is critical.

Gladstone Experts Srivastava Lab

Article August 12, 2025

Gladstone Mourns the Loss of Founding Trustee Richard D. Jones

Jones lent Gladstone his time and expertise for nearly 50 years.

History Institutional News

Gladstone in the News August 8, 2025

Lab-Grown Salmon Introduced by Bay Area-Based Seafood Company

ABC7 News—Gladstone alumnus Arye Elfenbein and his business partner, Justin Kolbeck, founded Wildtype to create cell-cultured seafood. Their company uses the same technology—known as induced pluripotent stem cells—that Elfenbein learned while working in the lab of Deepak Srivastava at Gladstone.

Gladstone Experts Srivastava Lab

Article August 6, 2025

How Do Vaccines Work?

An in-depth explainer about different types of vaccines and what happens in the body after vaccination.

Gladstone Experts COVID-19 Deep Dive

Gladstone in the News August 1, 2025

Jennifer Doudna Is Named 2026 Priestley Medalist

Chemical & Engineering News—Gladstone Investigator Jennifer Doudna is receiving the highest honor given by the American Chemical Society for discoveries on ribozyme function and CRISPR gene editing, and for her international science leadership.

Awards Gladstone Experts Doudna Lab

Video July 30, 2025

Our Research Is Explicitly Focused on Solving Disease | The Gladstone Difference

Gladstone unites more than 600 biologists, chemists, engineers, and data scientists, combining diverse expertise to uncover how the human body functions—and what drives disease.

Communications Gladstone Experts Institutional News

Gladstone in the News July 28, 2025

Gladstone Institutes Develops AI-Powered Thinking Microscope

ABC7 News—Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, describes the revolutionary thinking microscope that his team developed to help identify better treatments for diseases like Alzheimer’s, Parkinson’s, and ALS.

Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Center for Systems and Therapeutics Finkbeiner Lab

Article July 28, 2025

Blood Vessels and Immune Cells Drive Risk for Alzheimer’s and Stroke

Gladstone scientists show that known genetic risk factors for neurological diseases act in the brain’s blood vessels and immune cells, revealing new targets for therapies.

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Corces Lab Pollard Lab Yang Lab

Article July 22, 2025

Pregnancy, Lactation Shape Immune Response to COVID-19 Vaccine and Infection

Study finds strong immune defenses in pregnant and lactating women, with key benefits that could guide future vaccine design.

News Release Research (Publication) COVID-19 Infectious Disease Roan Lab

Gladstone in the News July 21, 2025

Two Cancer Drugs Show Surprising Promise in Treating Alzheimer’s

Discover Magazine—With so few Alzheimer’s drugs available, repurposing medications approved for other conditions could be the key to tackling this complex disease. In fact, Gladstone Investigator Yadong Huang and his colleagues at UCSF discovered that a combination of two cancer drugs could reduce brain degeneration and restore memory, pointing toward a potent treatment path never considered before.

Gladstone Experts Alzheimer’s Disease Huang Lab

Gladstone in the News July 21, 2025

Could Cancer Drugs Be the Future of Alzheimer’s Treatment?

NBC News—Gladstone Investigator Yadong Huang comments on a new study he helped lead, in which two cancer drugs showed signs of slowing or reversing symptoms of Alzheimer’s disease.

Gladstone Experts Alzheimer’s Disease Huang Lab

Article July 21, 2025

Inside the Brain: Tackling Neurological Disease at Its Roots

For World Brain Day, discover some of Gladstone’s latest breakthroughs in neurological research.

Gladstone Experts Research (Publication) Alzheimer’s Disease COVID-19 Parkinson’s Disease Neurological Disease Akassoglou Lab Corces Lab Huang Lab Mucke Lab